259 related articles for article (PubMed ID: 10417751)
1. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
2. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid.
Baker EA; Leaper DJ
Wound Repair Regen; 2000; 8(5):392-8. PubMed ID: 11115151
[TBL] [Abstract][Full Text] [Related]
3. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
4. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts.
Weckroth M; Vaheri A; Myöhänen H; Tukiainen E; Sirén V
Wound Repair Regen; 2001; 9(4):314-22. PubMed ID: 11679140
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
7. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
[TBL] [Abstract][Full Text] [Related]
8. Wound fluids and the pathogenesis of chronic wounds.
Wysocki AB
J Wound Ostomy Continence Nurs; 1996 Nov; 23(6):283-90. PubMed ID: 9043277
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled gelatin degradation in non-healing chronic wounds.
Trøstrup H; Holstein P; Karlsmark T; Moser C; Ågren MS
J Wound Care; 2018 Nov; 27(11):724-734. PubMed ID: 30398935
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
Quax PH; de Bart AC; Schalken JA; Verheijen JH
Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activation in venous leg ulcers.
Herouy Y; Trefzer D; Hellstern MO; Stark GB; Vanscheidt W; Schöpf E; Norgauer J
Br J Dermatol; 2000 Nov; 143(5):930-6. PubMed ID: 11069499
[TBL] [Abstract][Full Text] [Related]
12. Vascular extracellular matrix remodeling in cerebral aneurysms.
Bruno G; Todor R; Lewis I; Chyatte D
J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in early and late gestational mouse skin and skin wounds.
Huang EY; Wu H; Island ER; Chong SS; Warburton D; Anderson KD; Tuan TL
Wound Repair Regen; 2002; 10(6):387-96. PubMed ID: 12453143
[TBL] [Abstract][Full Text] [Related]
14. Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9.
Tarlton JF; Vickery CJ; Leaper DJ; Bailey AJ
Br J Dermatol; 1997 Oct; 137(4):506-16. PubMed ID: 9390324
[TBL] [Abstract][Full Text] [Related]
15. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
17. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
18. The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors.
Cullen B; Silcock D; Brown LJ; Gosiewska A; Geesin JC
Int J Biochem Cell Biol; 1997 Jan; 29(1):241-50. PubMed ID: 9076959
[TBL] [Abstract][Full Text] [Related]
19. Developmental differences in the expression and modulation of extracellular matrix proteases and inhibitors in mouse skin fibroblasts.
Island E; Wu H; Warburton D; Anderson K; Tuan TL
Wound Repair Regen; 1999; 7(6):467-76. PubMed ID: 10633006
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic activity in leg ulcer exudate.
Palolahti M; Lauharanta J; Stephens RW; Kuusela P; Vaheri A
Exp Dermatol; 1993 Feb; 2(1):29-37. PubMed ID: 8156167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
